GENEVA, March 23 -- OBLITA THERAPEUTICS BVBA (Oostmallebaan 872980 Zoersel) filed a patent application (PCT/EP2025/076064) for "OLEYLPHOSPHOCHOLINE IN THE TREATMENT OF LEISHMANIASIS" on Sep 12, 2025. With publication no. WO/2026/057797, the details related to the patent application was published on Mar 19, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): JANSEN, Caroline (c/o Oostmallebaan 872980 Zoersel)
Abstract: The present invention provides therapeutic and/or prophylactic treatments against leishmaniasis in non-human mammals in need of such treatment, said treatments comprising administ...